AU2001257547A1 - Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders - Google Patents

Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders

Info

Publication number
AU2001257547A1
AU2001257547A1 AU2001257547A AU2001257547A AU2001257547A1 AU 2001257547 A1 AU2001257547 A1 AU 2001257547A1 AU 2001257547 A AU2001257547 A AU 2001257547A AU 2001257547 A AU2001257547 A AU 2001257547A AU 2001257547 A1 AU2001257547 A1 AU 2001257547A1
Authority
AU
Australia
Prior art keywords
cox
inhibitors
prevention
treatment
ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257547A
Inventor
Rebanta Bandyopadhyay
David Eveleth
Tugrul T Kararli
Satish K. Singh
Tom Van Haarlem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia LLC filed Critical Pharmacia LLC
Publication of AU2001257547A1 publication Critical patent/AU2001257547A1/en
Abandoned legal-status Critical Current

Links

AU2001257547A 2000-07-13 2001-05-04 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders Abandoned AU2001257547A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60218101 2000-07-13
US60/218,101 2000-07-13
US60279285 2001-03-28
US60/279,285 2001-03-28

Publications (1)

Publication Number Publication Date
AU2001257547A1 true AU2001257547A1 (en) 2002-07-08

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
IL151946A0 (en) 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
HK1068885A1 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n--
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
WO2002005848A3 (en) Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002240463A1 (en) Use of endostatin in the treatment of ocular neovascularization
AU2002363411A1 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
PL375631A1 (en) Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
AU7601400A (en) Treatment and prevention of hepatic disorders
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2001257547A1 (en) Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
AU2002333378A1 (en) Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response